Safety and Efficacy of SHPL-49 Injection in Participants With Acute Ischemic Stroke

NCT06202378 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: 3 ampoules of SHPL-49 Injection
DRUG: 6 ampoules of SHPL-49 Injection
DRUG: 0.9% Sodium Chloride Injection

Sponsor

Shanghai Hutchison Pharmaceuticals Limited

Collaborators

[object Object]